MedPath

Mannitol

Mannitol Injection, USP

Approved
Approval ID

c395e13d-6ea1-4104-8b37-669cfb982f04

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 16, 2023

Manufacturers
FDA

Fresenius Kabi USA, LLC

DUNS: 608775388

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

MANNITOL

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code63323-024
Application NumberANDA080677
Product Classification
M
Marketing Category
C73584
G
Generic Name
MANNITOL
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateMarch 16, 2023
FDA Product Classification

INGREDIENTS (1)

MANNITOLActive
Quantity: 250 mg in 1 mL
Code: 3OWL53L36A
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Mannitol - FDA Drug Approval Details